Initial clinical evidence that mofetil mycophenolate (MMF) antiviral effects may delay the recurrence of hepatitis C (HEP C) and reduce the incidence of CMB infection in HEP C liver transplant recipients (OLT).

被引：0
|
作者：
Fasola, CG [1 ]
Netto, G [1 ]
Jennings, LW [1 ]
Jung, GJ [1 ]
Marubashi, S [1 ]
Sanchez, EQ [1 ]
Molmenti, EP [1 ]
Gonwa, TA [1 ]
Goldstein, RM [1 ]
Klintmalm, GB [1 ]
机构：
[1] Baylor Univ, Med Ctr, Dallas, TX USA
来源：
HEPATOLOGY | 2000年 / 32卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
517
引用
收藏
页码：290A / 290A
页数：1
相关论文
共 15 条
  • [1] Natural history of recurrence of hepatitis C (HEP CR) in liver transplant recipients (OLT) under mycophenolate mofetil (MMF) immunosuppression (IS).
    Fasola, CG
    Netto, GJ
    Christensen, LL
    Molmenti, EP
    Gonwa, TA
    Goldstein, RM
    Levy, MF
    Klintmalm, GB
    HEPATOLOGY, 2001, 34 (04) : 639A - 639A
  • [2] Optimal dosing of mycophenolate mofetil (MMF) is necessary to delay hepatitis C recurrence (HEP CR) in liver transplant recipients.
    Fasola, CG
    Netto, GJ
    Christensen, LL
    Sanchez, EQ
    Molmenti, EM
    Gonwa, TA
    Goldstein, RM
    Levy, MF
    Klintmalm, GB
    HEPATOLOGY, 2001, 34 (04) : 639A - 639A
  • [3] Does mofetil mycophenolate (MMF) delay hepatitis C recurrence in liver transplant patients?
    Fasola, CG
    Netto, GJ
    Jennings, LW
    Gonwa, TA
    Goldstein, RM
    Levy, MF
    Molmenti, EP
    Klintmalm, GB
    TRANSPLANTATION, 2000, 69 (08) : S120 - S120
  • [4] Recurrence of hepatitis C in liver transplant recipients treated with mycophenolate mofetil
    Fasola, CG
    Netto, GJ
    Jennings, LW
    Christensen, LL
    Molmenti, EP
    Sanchez, EQ
    Levy, MF
    Goldstein, RM
    Klintmalm, GB
    TRANSPLANTATION PROCEEDINGS, 2002, 34 (05) : 1563 - 1564
  • [5] Hepatitis C recurrence (HCVR) in liver transplant recipients (OLT) under mycophenolate mofetil (MMF) immunosuppression (IS): A long-term follow up
    Fasola, CG
    Netto, GJ
    Sanchez, EQ
    Chinnakotla, S
    Levy, MF
    Goldstein, RM
    Klintmalm, GB
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 356 - 356
  • [6] Delay of hepatitis C recurrence in liver transplant recipients: Impact of mycophenolate mofetil on transplant recipients with severe acute rejection or with renal dysfunction
    Fasola, CG
    Netto, GJ
    Christensen, LL
    Molmenti, EP
    Sanchez, EQ
    Levy, MF
    Goldstein, RM
    Klintmalm, GB
    TRANSPLANTATION PROCEEDINGS, 2002, 34 (05) : 1561 - 1562
  • [7] Efficacy of mycophenolate mofetil (MMF) in liver transplant recipients: Results of a randomized double blind comparative study with an analysis of the impact of hepatitis C.
    Rabkin, JM
    Kalayoglu, M
    Klintmalm, G
    Langnas, AM
    Levy, GA
    Mamelok, RD
    McDiarmid, SV
    McMaster, P
    Merion, R
    Wang, W
    Wiesner, RH
    TRANSPLANTATION, 2000, 69 (08) : S118 - S118
  • [8] Hepatitis C (HCV)-3 Study: Decreased Incidence of Severe HCV Recurrence (R) Post Liver Transplantation (OLT) in Patients (Pt) Treated with Mycophenolate Mofetil (MMF), Particularly, in the Absence of Steroids (Pred).
    Klintmalm, Goran B.
    Fasola, Carlos G.
    Jennings, Linda
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 206 - 206
  • [9] HEPATITIS C (HCV)-3 STUDY: DECREASED INCIDENCE OF SEVERE HCV RECURRENCE (R) POST LIVER TRANSPLANTATION (OLT) IN PATIENTS (pt) TREATED WITH MYCOPHENOLATE MOFETIL (MMF), PARTICULARLY, IN THE ABSENCE OF STEROIDS (Pred)
    Klintmalm, Goran B.
    Fasola, Carlos G.
    Jennings, Linda
    LIVER TRANSPLANTATION, 2009, 15 (07) : S186 - S187
  • [10] HEPATITIS C(HCV)-3 STUDY: SEVERE HCV RECURRENCE (R) POST LIVER TRANSPLANTATION (OLT) IS DECREASED IN PATIENTS TREATED WITH MYCOPHENOLATE MOFETIL (MMF), PARTICULARLY, IN THE ABSENCE OF STEROIDS (PRED)
    Klintmalm, Goran
    Fasola, Carlos G.
    Jennings, Linda
    Heffron, Thomas G.
    Sher, Linda S.
    Mulligan, David C.
    Douglas, David D.
    Brown, Robert S.
    Ham, John M.
    Teperman, Lewis W.
    Rudich, Steven M.
    Eckhoff, Devin E.
    Washburn, Ken
    Millis, Michael
    Roberts, John P.
    Charlton, Michael R.
    Baliga, Prabhakar
    Pruett, Timothy L.
    Koneru, Baburao
    Pomfret, Elizabeth A.
    Abecassis, Michael M.
    HEPATOLOGY, 2008, 48 (04) : 338A - 338A
12